Changzhou Maokang Medical Products Co., Ltd – FDA 483, Aug 24, 2018
Changzhou Maokang Medical Products Co., Ltd, a contract manufacturer in Changzhou, China, was cited for significant deficiencies in laboratory record-keeping and drug product release testing. The inspection revealed issues with incomplete electronic data, discrepancies between printed and electronic records, and a lack of proper review procedures for analytical data. Additionally, the firm's testing methods for drug product release were found to be inadequate, failing to ensure conformance to final specifications.
ID · 0dcb821d-f3e1-485a-b544-fcf4912db9c2
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.